SCHEDULE: Danaos Ownership Update: Coustas Family Stake at 51.8%

Danaos Corporation's latest Schedule 13D/A filing reveals an updated beneficial ownership of 51.8% for Dr. John Coustas and the 883 Trust, reflecting recent equity awards and share acquisitions.

Summary

• Dr. John Coustas and Danaos Investment Limited, as Trustee of the 883 Trust, collectively beneficially own 9,538,502 shares of Danaos Corporation Common Stock.
• This represents 51.8% of the outstanding shares of Common Stock.
• The beneficial ownership was updated to reflect a grant of 100,000 shares to Dr. Coustas as a compensatory equity award on November 14, 2025.
• An additional 100,000 shares were acquired by Danaos Investment Limited pursuant to the Amended and Restated Management Agreement.
• The reported percentage also accounts for repurchases under the Company's common stock repurchase program.
• Iraklis Prokopakis beneficially owns 200,270 shares, or approximately 1.1% of the outstanding shares.
• Evangelos Chatzis beneficially owns 50,000 shares, or less than 1.0% of the outstanding shares.
• Dimitrios Charkoplias beneficially owns 120 shares, or less than 1.0% of the outstanding shares.

Sentiment

Score: 5

Explanation: The filing is a routine update on beneficial ownership, reflecting expected corporate actions like equity awards and share repurchases. It is neutral in sentiment, providing factual information without indicating significant positive or negative shifts in company performance or strategy.

Positives

• Increased ownership by Dr. John Coustas and the 883 Trust, potentially signaling confidence in the company's future.
• Compensatory equity award to Dr. Coustas aligns management incentives with shareholder interests.

Future Outlook

No specific forward-looking statements or guidance are provided in this filing.

Management Comments

• Dr. Coustas has certain powers to remove and replace DIL as Trustee of the 883 Trust and, accordingly, he may be deemed to beneficially own these 9,538,502 shares of Common Stock. This does not necessarily imply economic ownership of the securities.

Industry Context

This filing is an update on insider ownership and does not provide broader industry context. It reflects internal corporate actions (equity awards, management agreements) and share repurchase programs, which are common across industries but not specific to the shipping sector in this document.

Corporate Governance

Related Party Transactions

• 100,000 shares of Common Stock were granted to Dr. John Coustas, a key executive and beneficial owner, as a compensatory equity award on November 14, 2025.
• 100,000 shares were acquired by Danaos Investment Limited (Trustee of the 883 Trust, whose beneficiaries include Dr. Coustas and his family) pursuant to the Amended and Restated Management Agreement.
• The Amended and Restated Management Agreement, dated August 1, 2025, is between Danaos Corporation and Danaos Shipping Company Limited (a related entity).
• The Amended and Restated Brokerage Services Agreement, dated August 1, 2025, is among Danaos Corporation and Danaos Chartering Services Inc. (a related entity).

Stakeholder Impact

• Shareholders: The update clarifies the significant ownership stake of Dr. Coustas and the 883 Trust (51.8%), which could influence voting matters and strategic direction. The share repurchases mentioned could increase earnings per share for remaining shareholders.
• Management/Employees: Dr. Coustas received a compensatory equity award, aligning his interests with long-term company performance.

Next Steps

• The company will continue to operate under the Amended and Restated Management Agreement and Brokerage Services Agreement.
• The company's common stock repurchase program is ongoing, which may further impact outstanding share count and beneficial ownership percentages.

Key Dates

Keywords

Danaos Corporation, DANAOS, John Coustas, Schedule 13D, beneficial ownership, equity award, common stock, 883 Trust, corporate governance, shareholding